Fate Therapeutics FATE
NASDAQ FATE
$2.38 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Assets (2012 - 2026)

Updated

Fate Therapeutics (FATE) recorded Assets of $260.1 million in Q2 2026, down 30.0% from $371.63 million a year earlier and down 8.7% from the prior quarter.

Analysis

Fate Therapeutics (FATE) Assets (2012 - 2026) Analysis & Trends

At the end of FY2025, Fate Therapeutics reported Assets of $318.94 million, down 27.6% from FY2024.

  • Annual Assets has declined for four straight years, with a five-year compound annual growth rate of -12.5% (FY2020 to FY2025).
  • Across earlier years, Assets came in at $440.69 million in FY2024 (-12.9%), $506.22 million in FY2023 (-28.3%), $705.56 million in FY2022 (-23.4%) and $921.46 million in FY2021 (+48.0%).
  • The Q2 2026 figure is the lowest quarterly Assets since Q2 2019.
  • On a year-over-year basis, Assets has declined for 18 consecutive quarters, with an average decline of 24.8% over the last eight quarters.
  • Peak year-over-year performance for Assets in the last five years was growth of 57.2% in Q3 2021, against a decline of 30.6% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $284.92 million (Q1 2026), $318.94 million (Q4 2025) and $343.67 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Fate Therapeutics 277.73 Mn 277.73 Mn - 260.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 260.10 Mn
Mar 31, 2026 284.92 Mn
Dec 31, 2025 318.94 Mn
Sep 30, 2025 343.67 Mn
Jun 30, 2025 371.63 Mn
Mar 31, 2025 398.67 Mn
Dec 31, 2024 440.69 Mn
Sep 30, 2024 494.97 Mn
Jun 30, 2024 528.82 Mn
Mar 31, 2024 569.89 Mn
Dec 31, 2023 506.22 Mn
Sep 30, 2023 543.79 Mn
Jun 30, 2023 584.76 Mn
Mar 31, 2023 630.34 Mn
Dec 31, 2022 705.56 Mn
Sep 30, 2022 749.35 Mn
Jun 30, 2022 807.06 Mn
Mar 31, 2022 858.39 Mn
Dec 31, 2021 921.46 Mn
Sep 30, 2021 984.57 Mn
API Access

Fate Therapeutics Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=FATE&period=max&api_key=YOUR_API_KEY